Euclidean Capital LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$238.0B
Holdings
11
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (11 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VEUVANGUARD INTL EQUITY INDEX F | 2,578,184 | $184.0B | 77.31% | |
| 2 | INDAISHARES TR | 369,600 | $19.2B | 8.08% | |
| 3 | ORICORIC PHARMACEUTICALS INC | 989,410 | $11.9B | 4.99% | |
| 4 | FHTXFOGHORN THERAPEUTICS INC | 1,573,761 | $7.7B | 3.23% | |
| 5 | ALECALECTOR INC | 1,307,858 | $3.9B | 1.63% | |
| 6 | PMVPPMV PHARMACEUTICALS INC | 2,627,643 | $3.7B | 1.55% | |
| 7 | SPYSPDR S&P 500 ETF TR | 4,104 | $2.7B | 1.15% | |
| 8 | RAPTRAPT THERAPEUTICS INC | 82,234 | $2.1B | 0.89% | |
| 9 | TNYATENAYA THERAPEUTICS INC | 1,015,705 | $1.6B | 0.69% | |
| 10 | SRZNSURROZEN INC | 87,696 | $1.1B | 0.47% | |
| 11 | SRZNWSURROZEN INC | 170,833 | $3.4M | 0.00% |